David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Western Digital
WDC
$157B
| $13.7M | 0.02% |
209,649
+179,372
| +592% | +$11.9M |
|
752
Sensata Technologies
ST
$6.11B
| $13.7M | 0.02% |
284,481
-110,625
| -28% | -$5M |
|
|
DYN
753
DELISTED
Dynegy, Inc.
DYN
| $13.6M | 0.02% |
1,392,803
-353,971
| -20% | -$3.16M |
|
754
Deckers Outdoor
DECK
$12.5B
| $13.6M | 0.02% |
1,195,716
-290,682
| -20% | -$3.13M |
|
755
PUT
Align Technology
ALGN
$11.3B
| $13.6M | 0.02% |
72,800
+23,800
| +49% | +$4.07M |
|
756
Stride
LRN
$3.54B
| $13.5M | 0.02% |
759,060
+56,910
| +8% | +$1.01M |
|
757
Thermo Fisher Scientific
TMO
$232B
| $13.5M | 0.02% |
71,235
-300,848
| -81% | -$54.5M |
|
758
Best Buy
BBY
$18.4B
| $13.4M | 0.02% |
235,649
-1,041,922
| -82% | -$59.7M |
|
759
Telus
TU
$15.5B
| $13.4M | 0.02% |
744,000
-93,184
| -11% | -$1.67M |
|
|
ACOR
760
DELISTED
Acorda Therapeutics
ACOR
| $13.3M | 0.02% |
4,699
-457
| -9% | -$1.2M |
|
|
FBC
761
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $13.3M | 0.02% |
375,322
-54,723
| -13% | -$1.76M |
|
|
GCP
762
DELISTED
GCP Applied Technologies Inc.
GCP
| $13.2M | 0.02% |
430,282
-9,916
| -2% | -$297K |
|
|
GLUU
763
DELISTED
Glu Mobile Inc.
GLUU
| $13.2M | 0.02% |
3,513,034
+782,343
| +29% | +$2.46M |
|
764
AES
AES
$10.5B
| $13.2M | 0.02% |
1,195,490
+579,825
| +94% | +$6.47M |
|
765
Brixmor Property Group
BRX
$9.08B
| $13.1M | 0.02% |
696,743
-258,418
| -27% | -$4.91M |
|
|
ILG
766
PUT
DELISTED
ILG, Inc Common Stock
ILG
| $13.1M | 0.02% |
489,100
+60,000
| +14% | +$1.59M |
|
767
PUT
BP
BP
$113B
| $13.1M | 0.02% |
377,015
-6,494
| -2% | -$206K |
|
768
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.23B
| $13.1M | 0.02% |
161,000
+28,000
| +21% | +$2.26M |
|
769
Pultegroup
PHM
$24.7B
| $13.1M | 0.02% |
477,971
+80,400
| +20% | +$2.03M |
|
770
Hanover Insurance
THG
$7.92B
| $13.1M | 0.02% |
134,769
-150,579
| -53% | -$14.3M |
|
|
UNVR
771
DELISTED
Univar Solutions Inc.
UNVR
| $13.1M | 0.02% |
451,532
+29,538
| +7% | +$848K |
|
772
Boyd Gaming
BYD
$5.89B
| $13M | 0.02% |
500,000
+40,000
| +9% | +$1.04M |
|
773
Axalta
AXTA
$7.72B
| $13M | 0.02% |
449,565
-394,700
| -47% | -$11.9M |
|
774
Primerica
PRI
$9.23B
| $13M | 0.02% |
159,229
+60,292
| +61% | +$4.71M |
|
|
CLVS
775
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $13M | 0.02% |
157,600
+57,600
| +58% | +$4.57M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.